DocMorris AG (OTCPK:ZRSEF)
$ 42.5008 6.2808 (17.34%) Market Cap: 639.40 Mil Enterprise Value: 782.72 Mil PE Ratio: 0 PB Ratio: 1.40 GF Score: 62/100

Half Year 2022 Zur Rose Group AG Earnings Call Transcript

Aug 18, 2022 / 09:00AM GMT
Release Date Price: $63.15
Operator

Good day, and welcome to the Zur Rose Group AG 2022 Half Year Results Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Walter Hess. Please go ahead, sir.

Walter Hess
Zur Rose Group AG - CEO & Member of Executive Board

Good morning, and welcome to everybody. Marcel and I, we are very happy to present to you the half year results today. The world is facing many turbulences at the moment, resulting in uncertainties in the markets. Whereas our business with pharmaceuticals is hardly impacted by all of that. On the contrary, our key messages for you today are that we have set all our key priority on achieving EBITDA breakeven already in 2023. And as a result, there is no additional cash needed for operational business.

Our highly efficient distribution center in Heerlen is live. And the medpex brands integration has started. And with the rollout of the eRx in Germany, the digitalization of a EUR 50 billion market with prescribed medication will take off now.

So let's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot